| MeSH term | MeSH ID | Detail |
|---|---|---|
| Heart Failure | D006333 | 36 associated lipids |
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Osteitis | D010000 | 10 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| Osteolysis | D010014 | 8 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Osteoarthritis, Hip | D015207 | 4 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Dynybil C et al. | [The effect of osteoprotegerin on tendon-bone healing after reconstruction of the anterior cruciate ligament: a histomorphological and radiographical study in the rabbit]. | 2006 Mar-Apr | Z Orthop Ihre Grenzgeb | pmid:16625448 |
| Endres S et al. | [Comparative in vitro analysis of vacuum plasma-sprayed titanium implants--evaluation of OPG, Osteokalzin and AP expression]. | 2006 Nov-Dec | Z Orthop Ihre Grenzgeb | pmid:17187340 |
| An JJ et al. | Expression and regulation of osteoprotegerin in adipose tissue. | 2007 | Yonsei Med. J. | pmid:17963332 |
| Xiao HL et al. | [Expression and activity determination of TNFR domain of osteoprotegerin in E.coli and corresponding antibody preparation]. | 2005 | Yi Chuan | pmid:16257908 |
| Geng L et al. | [Association between Val80 polymorphism of the CYP19 gene, A163G polymorphism of the OPG gene and bone mineral density in post-menopausal Chinese women]. | 2007 | Yi Chuan | pmid:17989043 |
| Ming LG et al. | [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. | 2012 | Yao Xue Xue Bao | pmid:22512027 |
| Qiu S et al. | [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. | 2012 | Yao Xue Xue Bao | pmid:22993856 |
| Wang L et al. | [Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action]. | 2006 | Yao Xue Xue Bao | pmid:16927832 |
| Kang BH et al. | [Expression of truncated fragment of human OPG in CHO-DHFR- cells and its bioactivity characterization]. | 2009 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:19900367 |
| Shao B et al. | [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. | 2013 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:24321069 |
| Miyaji Y et al. | Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats. | 2009 | Xenobiotica | pmid:19255937 |
| Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
| Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
| Fahrleitner-Pammer A et al. | Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. | 2003 | Wien. Klin. Wochenschr. | pmid:12793029 |
| Fahrleitner A et al. | Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. | 2002 | Wien. Klin. Wochenschr. | pmid:12602117 |
| Wagner D and Fahrleitner-Pammer A | Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? | 2010 | Wien Med Wochenschr | pmid:20714810 |
| Winzer M et al. | Glycitein decreases the generation of murine osteoclasts and increases apoptosis. | 2010 | Wien Med Wochenschr | pmid:20714813 |
| Gruber R | Cell biology of osteoimmunology. | 2010 | Wien Med Wochenschr | pmid:20714814 |
| Beke D et al. | [Clinical relevance of biomarkers in cancer related bone disease]. | 2007 | Wien Med Wochenschr | pmid:17922085 |
| Kerschan-Schindl K | Bone turnover in hyperparathyroidism. | 2013 | Wien Med Wochenschr | pmid:22805761 |